Ownership history in MACQUARIE GROUP LTD · 19 quarters on record
This page tracks every 13F SEC filing in which MACQUARIE GROUP LTD reported a position in IMMUNOVANT INC (IMVT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 122,100 | — | 0% | 0.00% | $2.0M | $16.12 |
| 2025 Q2 | UNCHANGED | 122,100 | — | 0% | 0.00% | $2.0M | $16.00 |
| 2025 Q1 | UNCHANGED | 122,100 | — | 0% | 0.00% | $2.1M | $17.09 |
| 2024 Q4 | REDUCED | 122,100 | -63,884 | -34.3% | 0.00% | $3.0M | $24.77 |
| 2024 Q3 | ADDED | 185,984 | +63,884 | +52.3% | 0.01% | $5.3M | $28.51 |
| 2024 Q2 | ADDED | 122,100 | +19,000 | +18.4% | 0.00% | $3.2M | $26.40 |
| 2024 Q1 | ADDED | 103,100 | +62,474 | +153.8% | 0.00% | $3.3M | $32.31 |
| 2023 Q4 | ADDED | 40,626 | +40,383 | +16618.5% | 0.00% | $1.7M | $42.13 |
| 2022 Q3 | REDUCED | 243 | -977 | -80.1% | 0.00% | $7K | $5.58 |
| 2022 Q2 | UNCHANGED | 1,220 | — | 0% | 0.00% | $5K | $3.90 |
As of 2025 Q4 — sorted by position size